All patients benefit equally from a supervised exercise program for claudication

Vascular and Endovascular Surgery

Volumn 41, Issue 3, 2007, Pages 212-216

  Serracino Inglott, Ferdinand ^a   Owen, Gareth ^a   Carter, Andrew ^a   Dix, Francis ^a   Smyth, John Vince ^a   Mohan, Irwin V ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

Claudication; Exercise; Peripheral vascular disease

Indexed keywords

ACETYLSALICYLIC ACID; ANTITHROMBOCYTIC AGENT; ATORVASTATIN; CLOPIDOGREL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; PRAVASTATIN; SIMVASTATIN;

ADULT; AGED; ARTICLE; CLAUDICATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG MEGADOSE; FEMALE; HEART FUNCTION; HUMAN; HYPERTENSION; KINESIOTHERAPY; MAJOR CLINICAL STUDY; MALE; PROSPECTIVE STUDY; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SHORT FORM 36; SMOKING; WALKING;

ADULT; AGED; AGED, 80 AND OVER; EXERCISE THERAPY; FEMALE; HEALTH STATUS INDICATORS; HUMANS; INTERMITTENT CLAUDICATION; MALE; MIDDLE AGED; QUALITY OF LIFE; TETRAZOLES; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 34250796317     PISSN: 15385744     EISSN: None     Source Type: Journal    
DOI: 10.1177/1538574407300913     Document Type: Article

References (24)

1. Fowkes FG, Gillespie IN Angioplasty (versus non surgical management) for intermittent claudication. Cochrane Database Syst Rev. 2000 ; 2: CD000017.
2. Whyman MR, Fowkes FG, Kerracher EM, et al. Is intermittent claudication improved by percutaneous transluminal angioplasty? A randomized controlled trial. J Vasc Surg. 1997 ; 26: 551-557.
3. Creasy TS, McMillan PJ, Fletcher EW, Collin J., Morris PJ Is percutaneous transluminal angioplasty better than exercise for claudication? Preliminary results from a prospective randomised trial. Eur J Vasc Surg. 1990 ; 4: 135-140.
4. Treesak C., Kasemsup V., Treat-Jacobson D., Nyman JA, Hirsch AT Cost-effectiveness of exercise training to improve claudication symptoms in patients with peripheral arterial disease. Vasc Med. 2004 ; 9: 279-285.
5. Turton EP, Coughlin PA, Kester RC, Scott DJ Exercise training reduces the acute inflammatory response associated with claudication. Eur J Vasc Endovasc Surg. 2002 ; 23: 309-336.
6. Tan KH, De Cossart L., Edwards PR Exercise training and peripheral vascular disease. Br J Surg. 2000 ; 87: 553-562.
7. Regensteiner JG Exercise rehabilitation for the patient with intermittent claudication: a highly effective yet underutilized treatment. Curr Drug Targets Cardiovasc Haematol Disord. 2004 ; 4: 233-239.
8. Brandsma JW, Robeer BG, van den Heuvel S., Smit B., Wittens CH, Oostendorp RA The effect of exercises on walking distance of patients with intermittent claudication: a study of randomized clinical trials. Phys Ther. 1998 ; 78: 278-286.
9. Robeer GG, Brandsma JW, van den Heuvel SP, Smit B., Oostendorp RA, Wittens CH Exercise therapy for intermittent claudication: a review of the quality of randomised clinical trials and evaluation of predictive factors. Eur J Vasc Endovasc Surg. 1998 ; 15: 36-43.
10. Patterson RB, Pinto B., Marcus B., Colucci A., Braun T., Roberts M. Value of a supervised exercise program for the therapy of arterial claudication. J Vasc Surg. 1997 ; 25: 312-318.
11. Scottish Physiotherapy Amputee Research Group (SPARG). SPARG Guidelines: Exercise Therapy for Patients with Intermittent Claudication. Glasgow, UK: SPARG ; 2001.
12. Regensteiner JG, Treat-Jacobson D., Walsh ME, et al. Partners: the impact of peripheral arterial disease (PAD) on health-related quality of life (HQL) [Abstract 1948]. Circulation. 2000 ; 102: II - 400.
13. Danielsson G., Albrechtsson U., Norgren L., et al. Percutaneous transluminal angioplasty of crural arteries: diabetes and other factors influencing outcome. Eur J Vasc Endovasc Surg. 2001 ; 21: 432-436.
14. Jensen LP, Schroeder TV, Lorentzen JE In situ saphenous vein bypass surgery in diabetic patients. Eur J Vasc Surg. 1992 ; 6: 533-539.
15. Quick CR, Cotton LT The measured effect of stopping smoking on intermittent claudication. Br J Surg. 1982 ; 69 (suppl): 24-26.
16. Gardner AW, Killewich LA, Montgomery PS, Katzel LI Response to exercise rehabilitation in smoking and non-smoking patients with intermittent claudication. J Vasc Surg. 2004 ; 39: 531-538.
17. Cahan MA, Montgomery P., Otis RB, Clancy R., Flinn W., Gardner A. The effect of cigarette smoking status on six-minute walk distance in patients with intermittent claudication. Angiology. 1999 ; 50: 537-546.
18. Kudo T., Chandra FA, Ahn SS Long-term outcomes and predictors of iliac angioplasty with selective stenting. J Vasc Surg. 2005 ; 42: 466-475.
19. Gentile AT, Mills JL, Gooden MA, et al. Identification of predictors for lower extremity vein graft stenosis. Am J Surg. 1997 ; 174: 218-221.
20. Barnett AH, Bradbury AW, Brittenden J., et al. The role of cilostazol in the treatment of intermittent claudication. Curr Med Res Opin. 2004 ; 20: 1661-1670.
21. Money SR, Herd JA, Isaacsohn JL, et al. Effect of cilostazol on walking distances in patients with intermittent claudication caused by peripheral vascular disease. J Vasc Surg. 1998 ; 27: 267-274.
22. Aronow WS, Nayak D., Woodworth S., Ahn C. Effect of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication in older patients with peripheral arterial disease at six months and at one year after treatment. Am J Cardiol. 2003 ; 92: 711-712.
23. Mondillo S., Ballo P., Barbati R., et al. Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease. Am J Med. 2003 ; 114: 359-364.
24. Mohler ER 3rd, Hiatt WR, Creager MA. Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease. Circulation. 2003 ; 108: 1481-1486.